More than 70% of patients with schwannomatoses develop single or multiple hybrid neurofibroma/schwannoma tumors, while over 25% of patients with NF2-related schwannomatosis exhibit at least one hybrid neurofibroma/schwannoma tumor. This evidence concerns the gene NF2 and schwannomatosis.